Cargando…
A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine
Malignant mesothelioma, closely linked with occupational asbestos exposure, is relatively rare in the frequency, but the patient numbers are going to increase in the next few decades all over the world. The current treatment modalities are not effective in terms of the overall survival and the quali...
Autores principales: | Tada, Yuji, Shimada, Hideaki, Hiroshima, Kenzo, Tagawa, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581274/ https://www.ncbi.nlm.nih.gov/pubmed/23484132 http://dx.doi.org/10.1155/2013/572609 |
Ejemplares similares
-
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
por: Ak, Guntulu, et al.
Publicado: (2017) -
Gene medicine for cancer treatment: Commercially available medicine and accumulated clinical data in China
por: Ma, Guangyu, et al.
Publicado: (2009) -
Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma
por: Tada, Yuji, et al.
Publicado: (2020) -
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene
por: Tada, Yuji, et al.
Publicado: (2015) -
An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol
por: Tada, Yuji, et al.
Publicado: (2016)